MedTrace Logo

Stem Cell Therapy in Chronic Ischemic Heart Failure

NCT00235417 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2007-06-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether intracoronary bone marrow transplantation can improve left ventricular ejection fraction in patients with severe ischemic heart failure and no other option for standard therapies (revascularization and drugs).

Conditions

  • Myocardial Ischemia
  • Heart Failure, Congestive

Interventions

PROCEDURE

Bone marrow transplantation

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Per Thayssen, MDSci · Department of Cardiology, Odense University Hospital

  • Axel CP Diederichsen, phd · Department of Cardiology, Odense University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2007-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235417 on ClinicalTrials.gov